A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...
Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...
Ipratropium bromide 0.03% (21mcg/spray); aqueous soln ... secretions from the serous and seromucous glands lining the nasal mucosa when applied locally. Epistaxis, pharyngitis, nasal dryness ...
Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%: Our Bureau,Mumbai Tuesday, January 28, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...
Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...
Ipratropium bromide nasal solution 0.06% is indicated for symptomatic relief of rhinorrhea associated with the common cold or ...
Grasim Industries, the flagship entity of the Aditya Birla Group, posted a consolidated net loss of ₹ 168.7 crore for Q3 FY25 ...
Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...
In this instance, antihistamine pills may again be of value, along with the nasal spray Atrovent, which blocks the action of the neurotransmitter released by the parasympathetic nerves.
Ipratropium bromide 0.06% (42mcg/spray); aqueous soln ... secretions from the serous and seromucous glands lining the nasal mucosa when applied locally. <5yrs: not recommended.